Hepion Pharmaceuticals, Inc.
General ticker "HEPA" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $980.6K (TTM average)
Hepion Pharmaceuticals, Inc. does not follow the US Stock Market performance with the rate: -9.3%.
Estimated limits based on current volatility of 10.8%: low 0.06$, high 0.07$
Factors to consider:
- Total employees count: 25 as of 2022
- Top business risk factors: Operational and conduct risks, Market competition, Cybersecurity threats, Pandemic risks, Labor/talent shortage/retention
- Current price 99.2% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [7.33$, 36.81$]
- 2025-12-31 to 2026-12-31 estimated range: [2.49$, 13.55$]
Financial Metrics affecting the HEPA estimates:
- Negative: with PPE of -0.1 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -601.65 <= 0.33
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Negative: Shareholder equity ratio, % of -115.47 <= 18.93
- Negative: Investing cash flow per share per price, % of -19.82 <= -14.38
- Negative: negative Industry operating income (median)
- Negative: Interest expense per share per price, % of 41.20 > 3.41
Short-term HEPA quotes
Long-term HEPA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $45.49MM | $48.45MM | $19.35MM |
| Operating Income | $-45.49MM | $-48.45MM | $-19.35MM |
| Non-Operating Income | $0.40MM | $-0.89MM | $3.18MM |
| Interest Expense | $0.01MM | $0.01MM | $1.25MM |
| R&D Expense | $33.27MM | $35.64MM | $11.85MM |
| Income(Loss) | $-45.08MM | $-49.34MM | $-16.16MM |
| Taxes | $-2.88MM | $-0.41MM | $-2.97MM |
| Profit(Loss)* | $-42.20MM | $-48.93MM | $-13.19MM |
| Stockholders Equity | $49.86MM | $7.28MM | $-1.86MM |
| Assets | $60.24MM | $18.09MM | $1.61MM |
| Operating Cash Flow | $-34.96MM | $-40.89MM | $-18.22MM |
| Capital expenditure | $0.02MM | $0.01MM | $0.00MM |
| Investing Cash Flow | $-0.01MM | $-0.01MM | $-0.60MM |
| Financing Cash Flow | $-5.14MM | $4.49MM | $4.35MM |
| Earnings Per Share** | $-602.86 | $-619.32 | $-107.35 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.